Pulse Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PLSE and other ETFs, options, and stocks.About PLSE
Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling.
CEOPaul A. LaViolette
CEOPaul A. LaViolette
Employees75
Employees75
HeadquartersMiami, Florida
HeadquartersMiami, Florida
Founded2014
Founded2014
Employees75
Employees75
PLSE Key Statistics
Market cap1.03B
Market cap1.03B
Price-Earnings ratio-13.44
Price-Earnings ratio-13.44
Dividend yield—
Dividend yield—
Average volume222.52K
Average volume222.52K
High today$15.96
High today$15.96
Low today$15.17
Low today$15.17
Open price$15.35
Open price$15.35
Volume253.47K
Volume253.47K
52 Week high$25.00
52 Week high$25.00
52 Week low$12.56
52 Week low$12.56
Stock Snapshot
Pulse Biosciences(PLSE) stock is priced at $15.20, giving the company a market capitalization of 1.03B. It carries a P/E multiple of -13.44.
On 2025-12-22, Pulse Biosciences(PLSE) stock moved within a range of $15.17 to $15.96. With shares now at $15.20, the stock is trading +0.2% above its intraday low and -4.8% below the session's peak.
Trading activity shows a volume of 253.47K, compared to an average daily volume of 222.52K.
The stock's 52-week range extends from a low of $12.56 to a high of $25.00.
The stock's 52-week range extends from a low of $12.56 to a high of $25.00.
People also own
Based on the portfolios of people who own PLSE. This list is generated using Robinhood data, and it’s not a recommendation.